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Background
Both schizophrenia and bipolar illness are associated with
a continuous spectrum of illness. In schizophrenia
patients range from the chronically hospitalized to the
employed and independent. Genetic studies of adopted
twins and families have supported the concept of a range
of severity appearing in the relatives of the severely ill.
Similarly in the bipolar spectrum, individuals range from
the severely agitated to the mildly activated. Mood varia-
tion and disordered thought may appear in both groups.
Factor-analytic approaches applied to symptoms have not
clearly supported a two-group dichotomy.
Material and methods
We examined cortical gray and white matter volumes in a
large sample including unmedicated schizophrenia-spec-
trum patients (n=79 SPD, n=57 schizophrenia) and
healthy controls (n=148). For the bipolar spectrum we
had 40 patients with bipolar spectrum (BPS) illnesses
(bipolar type I = 17, bipolar type II = 7, cyclothymia = 16)
and 36 sex- and age-matched control subjects.
Results
Within the schizophrenia spectrum, schizophrenia
patients had reduced gray matter volume widely across
the cortex but more marked in frontal and temporal lobes.
The SPD patients had reductions in the same regions but
only about half that observed in schizophrenia and spar-
ing was in key regions including BA10, superior and mid-
dle temporal gyrus. The BPS patients had significantly
reduced volume of the white and the gray matter of the
frontal cortex, findings also appearing in the schizophre-
nia spectrum.
Discussion
Taken together, the anatomical imaging findings are
indicative of significant brain size differences with psy-
chosis but do not strongly support the distinctiveness of
either illness from their respective spectra or from each
other. This may reflect imperfections in symptom-based
diagnosis, multidimensional illnesses, or the non-specifi-
city of brain volume decreases in psychiatric illness. Vari-
ation in the loss of Brodmann area 10 or lack of change in
Brodmann area 22 may provide clues to dimensions
related to severity of spectrum expression. Diffusion ten-
sor imaging may provide additional dimensional answers
to this diagnostic conundrum.
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